China CDC

China CDC
CCDC Weekly – Weekly Reports: Current Volume (3)
2021-06-25 / No. 26
PDF of this issue
:: Preplanned Studies: The Impact of COVID-19 on Tuberculosis Patients’ Behavior of Seeking Medical Care — China, 2020
:: Outbreak Reports: A Tuberculosis Outbreak During the COVID-19 Pandemic — Hubei Province, China, 2020
:: Healthy China: Practical Experiences of Delivering Multidrug-Resistant Tuberculosis Comprehensive Supportive Care Services in China

National Health Commission of the People’s Republic of China [to 26 Jun 2021]
June 26: Daily briefing on novel coronavirus cases in China
On June 25, 31 provincial-level regions and the Xinjiang Production and Construction Corps on the Chinese mainland reported 25 new cases of confirmed infections.

China committed to facilitating equitable vaccine distribution globally
BEIJING — Delta, the highly infectious coronavirus variant, has been reported in more than 90 countries and regions across the world, highlighting the urgency to mount a herd immunity defense through mass vaccination.
Some developing countries are left in scarcity of vaccines as certain countries have hoarded COVID-19 vaccines several folds more than the amount needed to vaccinate their populations.
To solve the problems of insufficient production capacity and an unbalanced distribution of COVID-19 vaccines, China has put forward its proposals on multiple international forums.
At the 73rd World Health Assembly in May 2020, China made a solemn commitment to making COVID-19 vaccines a “global public good,” offering its assistance in promoting fair accessibility to vaccines and affordability for developing countries.
At the Global Health Summit in late May, China called for the rejection of vaccine nationalism in a bid to make vaccines more accessible and affordable in the developing world.
China spares no effort to deliver on its promise in championing international cooperation in fighting the pandemic.
Despite a tight supply and huge domestic demand, China has provided over 350 million doses of COVID-19 vaccines for the international community, including vaccine aid provided for over 80 developing countries and those exported to more than 40 countries.
China has also pledged to provide the first batch of 10 million COVID-19 vaccine doses to COVAX, an initiative aimed to promote equitable access to vaccines initiated by the World Health Organization (WHO)…

National Medical Products Administration – PRC [to 26 Jun 2021]
Over 1.1 bln doses of COVID-19 vaccines administered in China
More than 1.1 billion doses of COVID-19 vaccines have been administered in China as of Thursday, the National Health Commission said on June 25.

NMPA holds meeting to review vaccine regulatory quality management system
The National Medical Products Administration (NMPA) held a vaccine regulatory quality management system review meeting on June 15, to summarize the construction and operation of the system, evaluate its appropriateness, effectiveness and adequacy, and make arrangements for the key tasks of the next stage of its construction.

China-UK drug regulatory cooperation project kicks off
The meeting adopted the plan for the China-UK drug regulatory cooperation project in 2021 to push forward technical exchanges in areas of drug review, inspection and post-marketing monitoring for better mutual understanding and deeper cooperation.